IL147593A0 - Pharmaceutical compositions containing fused hetrocyclic compounds - Google Patents

Pharmaceutical compositions containing fused hetrocyclic compounds

Info

Publication number
IL147593A0
IL147593A0 IL14759300A IL14759300A IL147593A0 IL 147593 A0 IL147593 A0 IL 147593A0 IL 14759300 A IL14759300 A IL 14759300A IL 14759300 A IL14759300 A IL 14759300A IL 147593 A0 IL147593 A0 IL 147593A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
containing fused
hetrocyclic compounds
hetrocyclic
Prior art date
Application number
IL14759300A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL147593A0 publication Critical patent/IL147593A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14759300A 1999-07-19 2000-07-19 Pharmaceutical compositions containing fused hetrocyclic compounds IL147593A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20447699 1999-07-19
PCT/JP2000/004858 WO2001005402A1 (fr) 1999-07-19 2000-07-19 Agents preventifs et therapeutiques du cancer

Publications (1)

Publication Number Publication Date
IL147593A0 true IL147593A0 (en) 2002-08-14

Family

ID=16491170

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14759300A IL147593A0 (en) 1999-07-19 2000-07-19 Pharmaceutical compositions containing fused hetrocyclic compounds

Country Status (18)

Country Link
US (1) US6569877B2 (xx)
EP (1) EP1197211A4 (xx)
KR (1) KR20020015383A (xx)
CN (1) CN1374864A (xx)
AU (1) AU760917B2 (xx)
BR (1) BR0012591A (xx)
CA (1) CA2379662A1 (xx)
CZ (1) CZ2002178A3 (xx)
HU (1) HUP0202340A3 (xx)
IL (1) IL147593A0 (xx)
MX (1) MXPA02000757A (xx)
NO (1) NO20020291L (xx)
NZ (1) NZ516636A (xx)
PL (1) PL352681A1 (xx)
RU (1) RU2219928C2 (xx)
TR (1) TR200200111T2 (xx)
WO (1) WO2001005402A1 (xx)
ZA (1) ZA200200316B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
US9092523B2 (en) 2005-02-28 2015-07-28 Search Engine Technologies, Llc Methods of and systems for searching by incorporating user-entered information
CN101523338B (zh) 2005-03-18 2016-10-19 搜索引擎科技有限责任公司 应用来自用户的反馈来改进搜索结果的搜索引擎
WO2007100027A1 (ja) * 2006-03-02 2007-09-07 Daiichi Sankyo Company, Limited 光学活性なチアゾリジンジオン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3152992B2 (ja) * 1992-04-03 2001-04-03 株式会社興人 過酸化脂質の生成抑制及び消去用組成物
CA2200598C (en) 1994-09-28 1999-12-07 Shuji Jinno Novel anti-oxidative, tricyclic, condensed heterocyclic compound
JP3820601B2 (ja) * 1995-03-27 2006-09-13 大塚製薬株式会社 活性酸素消去剤
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
KR100666887B1 (ko) 1997-10-08 2007-01-10 상꾜 가부시키가이샤 치환 축합 복소환 화합물
AU1507799A (en) * 1997-12-16 1999-07-05 Sankyo Company Limited Leukemia remedy
US6878896B2 (en) * 2002-07-24 2005-04-12 United Parcel Service Of America, Inc. Synchronous semi-automatic parallel sorting

Also Published As

Publication number Publication date
CZ2002178A3 (cs) 2002-05-15
CN1374864A (zh) 2002-10-16
WO2001005402A1 (fr) 2001-01-25
AU6021200A (en) 2001-02-05
NO20020291L (no) 2002-03-18
NO20020291D0 (no) 2002-01-18
TR200200111T2 (tr) 2002-08-21
RU2219928C2 (ru) 2003-12-27
CA2379662A1 (en) 2001-01-25
NZ516636A (en) 2004-01-30
US20020137776A1 (en) 2002-09-26
PL352681A1 (en) 2003-09-08
HUP0202340A2 (hu) 2003-02-28
EP1197211A4 (en) 2004-09-01
AU760917B2 (en) 2003-05-22
KR20020015383A (ko) 2002-02-27
US6569877B2 (en) 2003-05-27
BR0012591A (pt) 2002-04-09
HUP0202340A3 (en) 2006-03-28
MXPA02000757A (es) 2002-07-22
EP1197211A1 (en) 2002-04-17
ZA200200316B (en) 2003-06-25

Similar Documents

Publication Publication Date Title
IL145071A0 (en) Fused ring compounds and pharmaceutical compositions containing the same
HUP0204580A3 (en) Aryl fused azapolycyclic compounds and pharmaceutical compositions containing them
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
PL351387A1 (en) Pharmaceutical composition
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL155284A0 (en) Fused ring compounds and pharmaceutical compositions containing the same
IL156031A0 (en) Fused heterocyclic derivatives and pharmaceutical compositions containing the same
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
HUP0400058A2 (hu) Kondenzált heterogyűrűs vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
IL150447A0 (en) Pharmaceutical compositions containing entecavir
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
IL146434A0 (en) Pharmaceutical compositions containing ecteinascidin 743
GB9923436D0 (en) Pharmaceutical compositions
HUP0103924A3 (en) Oral pharmaceutical compositions containing buprenorphin
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0201714A3 (en) Substituted heterocyclic compounds and pharmaceutical compositions containing them
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
GB9904163D0 (en) Pharmaceutical compositions
GB2363572B (en) Pharmaceutical composition containing cyclosporin
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
HUP0003836A3 (en) Pharmaceutical compositions containing lasofoxifene
IL148725A0 (en) Aqueous pharmaceutical compositions containing circlesonide